OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Elise Landais, Penny L. Moore
Retrovirology (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Jun Wu, Boyun Liang, Cunrong Chen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 225

Multiple roles for HIV broadly neutralizing antibodies
Barton F. Haynes, Dennis R. Burton, John R. Mascola
Science Translational Medicine (2019) Vol. 11, Iss. 516
Open Access | Times Cited: 175

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Wilton B. Williams, S. Munir Alam, Gilad Ofek, et al.
Cell (2024) Vol. 187, Iss. 12, pp. 2919-2934.e20
Open Access | Times Cited: 18

Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
Christopher A. Cottrell, Jelle van Schooten, Charles A. Bowman, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 8, pp. e1008753-e1008753
Open Access | Times Cited: 78

Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa
Bavesh D Kana, Patrick Arbuthnot, Benjamin K Botwe, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 8, pp. e288-e300
Open Access | Times Cited: 23

Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth
Ryan S. Roark, Hui Li, Wilton B. Williams, et al.
Science (2020) Vol. 371, Iss. 6525
Open Access | Times Cited: 70

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
Sharana Mahomed, Nigel Garrett, Cheryl Baxter, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 3, pp. 370-380
Open Access | Times Cited: 63

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
Bin Su, Stefania Dispinseri, Valeria Iannone, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 56

B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models
Deli Huang, Robert Abbott, Colin Havenar‐Daughton, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 37, pp. 22920-22931
Open Access | Times Cited: 55

Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives
Sharana Mahomed
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 6

The complex challenges of HIV vaccine development require renewed and expanded global commitment
Linda‐Gail Bekker, Roger Tatoud, François Dabis, et al.
The Lancet (2019) Vol. 395, Iss. 10221, pp. 384-388
Closed Access | Times Cited: 53

Structural basis of broad HIV neutralization by a vaccine-induced cow antibody
Robyn L. Stanfield, Zachary T. Berndsen, Ruiqi Huang, et al.
Science Advances (2020) Vol. 6, Iss. 22
Open Access | Times Cited: 40

Next-generation bNAbs for HIV-1 cure strategies
Angela I. Schriek, Yoann Aldon, Marit J. van Gils, et al.
Antiviral Research (2023) Vol. 222, pp. 105788-105788
Open Access | Times Cited: 13

HIV-1 Vpu restricts Fc-mediated effector functions in vivo
Jérémie Prévost, Sai Priya Anand, Jyothi Krishnaswamy Rajashekar, et al.
Cell Reports (2022) Vol. 41, Iss. 6, pp. 111624-111624
Open Access | Times Cited: 22

Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens
Maddy L. Newby, Joel D. Allen, Max Crispin
Biotechnology Advances (2023) Vol. 70, pp. 108283-108283
Open Access | Times Cited: 12

Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth
Katrina M. Pollock, Hannah M. Cheeseman, Leon R. McFarlane, et al.
EBioMedicine (2025) Vol. 112, pp. 105544-105544
Open Access

Antigen affinity and site of immunization dictate B cell recall responses
Manon Termote, R. C. Marques, Erik Hyllner, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115221-115221
Open Access

Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV
Deepti Kannan, Eric Wang, Steven G. Deeks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Qian Wang, Linqi Zhang
Frontiers of Medicine (2019) Vol. 14, Iss. 1, pp. 30-42
Open Access | Times Cited: 32

Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
Christoph Kreer, Cosimo Lupo, Meryem S. Ercanoglu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10

Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses
Pia Dosenovic, Anna-Klara Pettersson, Abigail Wall, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 10, pp. 2316-2330
Open Access | Times Cited: 27

Antibody responses to the HIV-1 envelope high mannose patch
Christine N. Daniels, Kevin O. Saunders
Advances in immunology (2019), pp. 11-73
Open Access | Times Cited: 26

Page 1 - Next Page

Scroll to top